Artivion Gross Margin 2010-2022 | AORT

Current and historical gross margin for Artivion (AORT) over the last 10 years. The current gross profit margin for Artivion as of September 30, 2022 is %.
Artivion Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2022-09-30 $0.31B $0.20B 64.86%
2022-06-30 $0.31B $0.20B 65.58%
2022-03-31 $0.30B $0.20B 66.12%
2021-12-31 $0.30B $0.20B 66.44%
2021-09-30 $0.29B $0.19B 66.90%
2021-06-30 $0.28B $0.19B 66.79%
2021-03-31 $0.26B $0.17B 66.67%
2020-12-31 $0.25B $0.17B 66.40%
2020-09-30 $0.26B $0.17B 66.67%
2020-06-30 $0.26B $0.17B 66.67%
2020-03-31 $0.28B $0.18B 66.55%
2019-12-31 $0.28B $0.18B 66.06%
2019-09-30 $0.27B $0.18B 65.68%
2019-06-30 $0.27B $0.18B 66.05%
2019-03-31 $0.27B $0.18B 66.42%
2018-12-31 $0.26B $0.17B 66.03%
2018-09-30 $0.25B $0.17B 66.53%
2018-06-30 $0.23B $0.15B 66.52%
2018-03-31 $0.21B $0.14B 66.67%
2017-12-31 $0.19B $0.13B 67.89%
2017-09-30 $0.18B $0.12B 68.13%
2017-06-30 $0.18B $0.12B 67.76%
2017-03-31 $0.18B $0.12B 66.48%
2016-12-31 $0.18B $0.12B 66.11%
2016-09-30 $0.18B $0.12B 65.71%
2016-06-30 $0.17B $0.11B 64.67%
2016-03-31 $0.16B $0.10B 64.10%
2015-12-31 $0.15B $0.09B 62.59%
2015-09-30 $0.14B $0.09B 61.11%
2015-06-30 $0.14B $0.09B 61.81%
2015-03-31 $0.14B $0.09B 62.24%
2014-12-31 $0.15B $0.09B 62.76%
2014-09-30 $0.14B $0.09B 62.94%
2014-06-30 $0.14B $0.09B 62.68%
2014-03-31 $0.14B $0.09B 62.41%
2013-12-31 $0.14B $0.09B 63.12%
2013-09-30 $0.14B $0.09B 63.31%
2013-06-30 $0.14B $0.09B 63.24%
2013-03-31 $0.14B $0.09B 63.70%
2012-12-31 $0.13B $0.08B 64.12%
2012-09-30 $0.13B $0.08B 64.06%
2012-06-30 $0.13B $0.08B 64.00%
2012-03-31 $0.12B $0.08B 64.46%
2011-12-31 $0.12B $0.08B 63.87%
2011-09-30 $0.12B $0.08B 63.56%
2011-06-30 $0.12B $0.07B 61.21%
2011-03-31 $0.12B $0.07B 60.34%
2010-12-31 $0.12B $0.07B 59.48%
2010-09-30 $0.12B $0.07B 59.48%
2010-06-30 $0.12B $0.07B 61.21%
2010-03-31 $0.12B $0.07B 61.74%
2009-12-31 $0.11B $0.07B 62.50%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.566B $0.299B
Artivion Inc. is a medical device company. It focused on developing simple, elegant solutions which address cardiac and vascular surgeons. The company's group of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts and surgical sealants. Artivion Inc., formerly known as CryoLife Inc., is headquartered in suburban Atlanta, Georgia.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $230.517B 25.29
Edwards Lifesciences (EW) United States $50.772B 33.11
Alcon (ALC) Switzerland $37.369B 32.17
STERIS (STE) Ireland $21.864B 27.21
Teleflex (TFX) United States $12.124B 19.67
Fresenius Medical Care AG KGaA (FMS) Germany $11.123B 11.16
Penumbra (PEN) United States $9.913B 2372.91
Globus Medical (GMED) United States $7.950B 40.42
Glaukos (GKOS) United States $2.458B 0.00
Integer Holdings (ITGR) United States $2.435B 19.55
AVANOS MEDICAL, INC (AVNS) United States $1.469B 20.92
Nevro (NVRO) United States $1.410B 0.00
Paragon 28 (FNA) United States $1.346B 0.00